FDA Brief

Warning letters Drugs

FDA warning letter to

Crystal Clear Supplements

High riskIssued Feb 4, 2022Posted Feb 15, 2022Center for Drug Evaluation and Research | CDER

Crystal Clear Supplements took orders for tianeptine and other products FDA calls unapproved new drugs.

What happened

FDA reviewed the company’s website in December 2021, along with its Facebook and Instagram pages and product packaging. FDA found claims that products including tianeptine, phenibut, PEA, Noopept, L-theanine and lutein treat conditions such as depression, anxiety, ADHD, insomnia, cataracts, cancer and diabetes. FDA said these claims make the products unapproved new drugs sold without FDA approval.

What FDA found

  1. The company’s website, social media and packaging claimed the products treat diseases or affect body functions, so FDA treats them as drugs.

    FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)
  2. The products are not generally recognized as safe and effective for the claimed uses, so they are “new drugs.”

    FD&C Act section 201(p), 21 U.S.C. 321(p)
  3. The company introduced or delivered these new drugs into interstate commerce without FDA approval.

    FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)

What FDA wants

FDA tells the company to notify it in writing within 15 working days of steps taken to address the violations, including how it will prevent recurrence and supporting documents. If the company disagrees, FDA asks for its reasoning and supporting information.

Who should pay attention

  • retailers and online marketplaces selling tianeptine or nootropic products
  • brands making disease-treatment claims for supplements
  • clinicians and consumers encountering tianeptine products

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk